INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY, HEIDELBERG BIOLABS GMBH FILES APPLICATION FOR "SHORT VIRAL RNAS (SVRNAS) WITH THERAGNOSTIC POTENTIAL IN INFECTION WITH SARS-COV-2 AND RELATED VIRUSES"

GENEVA, July 3 -- THE JOHNS HOPKINS UNIVERSITY (3400 North Charles StreetBaltimore, Maryland 21218), HEIDELBERG BIOLABS GMBH (IM NEUENHEIMER FELD 58269120 HEIDELBERG) filed a patent application (PCT/US2024/061468) for "SHORT VIRAL RNAS (SVRNAS) WITH THERAGNOSTIC POTENTIAL IN INFECTION WITH SARS-COV-2 AND RELATED VIRUSES" on Dec 20, 2024. With publication no. WO/2025/137577, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WITWER, Kenneth W. (c/o THE JOHNS HOPKINS UNIVERSITY3400 North Charles StreetBaltimore, Maryland 21218...